Details for: XOLAIR
Company: NOVARTIS PHARMACEUTICALS CANADA INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02459787 | XOLAIR | OMALIZUMAB | 75 MG / 0.5 ML | SOLUTION | SUBCUTANEOUS |
| 02260565 | XOLAIR | OMALIZUMAB | 150 MG / VIAL | POWDER FOR SOLUTION | SUBCUTANEOUS |
| 02459795 | XOLAIR | OMALIZUMAB | 150 MG / ML | SOLUTION | SUBCUTANEOUS |
Summary Reports
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.